{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T10:44:36Z","timestamp":1782643476997,"version":"3.54.5"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,28]]},"DOI":"10.7759\/cureus.111647","type":"journal-article","created":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T09:49:56Z","timestamp":1782640196000},"source":"Crossref","is-referenced-by-count":0,"title":["Concomitant Diagnosis of Acute Promyelocytic Leukemia and Type 2 Diabetes Mellitus in a Child: Report of a Rare Case"],"prefix":"10.7759","author":[{"given":"Ikram","family":"El Hachmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayad","family":"Ghanam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziza","family":"Elouali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachid","family":"Seddik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rkain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1286106","article-title":"Long-term experience in treatment of acute promyelocytic leukemia in Mexican children in a tertiary care hospital","volume":"13","author":"Murillo-Maldonado MA","year":"2023","unstructured":"Murillo-Maldonado MA, Galv\u00e1n PG, Ortega IP, Morales FG, Villegas LJ, Acosta ED. Long-term experience in treatment of acute promyelocytic leukemia in Mexican children in a tertiary care hospital. Front Oncol. 2023, 13:1286106. 10.3389\/fonc.2023.1286106","journal-title":"Front Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1062524","article-title":"The treatment of acute promyelocytic leukemia in 2023: paradigm, advances, and future directions","volume":"12","author":"Iyer SG","year":"2022","unstructured":"Iyer SG, Elias L, Stanchina M, Watts J. The treatment of acute promyelocytic leukemia in 2023: paradigm, advances, and future directions. Front Oncol. 2022, 12:1062524. 10.3389\/fonc.2022.1062524","journal-title":"Front Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1377918","article-title":"Reassessing type 2 diabetes in adolescents and its management strategies based on insulin resistance","volume":"15","author":"Jia Q","year":"2024","unstructured":"Jia Q, Zhang Y, Zhang B, An X. Reassessing type 2 diabetes in adolescents and its management strategies based on insulin resistance. Front Endocrinol (Lausanne). 2024, 15:1377918. 10.3389\/fendo.2024.1377918","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000543033","article-title":"ISPAD clinical practice consensus guidelines 2024: type 2 diabetes in children and adolescents","volume":"97","author":"Shah AS","year":"2024","unstructured":"Shah AS, Barrientos-P\u00e9rez M, Chang N, et al.. ISPAD clinical practice consensus guidelines 2024: type 2 diabetes in children and adolescents. Horm Res Paediatr. 2024, 97:555-83. 10.1159\/000543033","journal-title":"Horm Res Paediatr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-S014","article-title":"14. Children and adolescents: standards of care in diabetes-2024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","unstructured":"American Diabetes Association Professional Practice Committee. 14. Children and adolescents: standards of care in diabetes-2024. Diabetes Care. 2024, 47:S258-81. 10.2337\/dc24-S014","journal-title":"Diabetes Care"},{"key":"ref6","article-title":"Prevalence of transient hyperglycemia and diabetes mellitus in pediatric patients with acute leukemia","volume":"4","author":"Banihashem A","year":"2014","unstructured":"Banihashem A, Ghasemi A, Ghaemi N, Moazzen N, Amirabadi A. Prevalence of transient hyperglycemia and diabetes mellitus in pediatric patients with acute leukemia. Iran J Ped Hematol Oncol. 2014, 4:5-10.","journal-title":"Iran J Ped Hematol Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179322","article-title":"Common genetic aberrations associated with metabolic interferences in human type-2 diabetes and acute myeloid leukemia: a bioinformatics approach","volume":"22","author":"Kyriakou TC","year":"2021","unstructured":"Kyriakou TC, Papageorgis P, Christodoulou MI. Common genetic aberrations associated with metabolic interferences in human type-2 diabetes and acute myeloid leukemia: a bioinformatics approach. Int J Mol Sci. 2021, 22:9322. 10.3390\/ijms22179322","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ20-0138","article-title":"The association between type 1 and 2 diabetes mellitus and the risk of leukemia: a systematic review and meta-analysis of 18 cohort studies","volume":"68","author":"Yan P","year":"2021","unstructured":"Yan P, Wang Y, Fu T, Liu Y, Zhang ZJ. The association between type 1 and 2 diabetes mellitus and the risk of leukemia: a systematic review and meta-analysis of 18 cohort studies. Endocr J. 2021, 68:281-9. 10.1507\/endocrj.EJ20-0138","journal-title":"Endocr J"},{"key":"ref9","article-title":"CDC growth charts: United States","author":"Kuczmarski RJ","year":"2000","unstructured":"Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al.. CDC growth charts: United States. Adv Data. 2000, 1-27.","journal-title":"Adv Data"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2471\/blt.07.043497","article-title":"Development of a WHO growth reference for school-aged children and adolescents","volume":"85","author":"de Onis M","year":"2007","unstructured":"de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007, 85:660-7. 10.2471\/blt.07.043497","journal-title":"Bull World Health Organ"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-266007","article-title":"Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome","volume":"115","author":"Sanz MA","year":"2010","unstructured":"Sanz MA, Montesinos P, Ray\u00f3n C, et al.. Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome. Blood. 2010, 115:5137-46. 10.1182\/blood-2010-01-266007","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2337\/dc26-S016","article-title":"16. Diabetes care in the hospital: standards of care in diabetes-2026","volume":"49","author":"American Diabetes Association Professional Practice Committee for Diabetes","year":"2026","unstructured":"American Diabetes Association Professional Practice Committee for Diabetes. 16. Diabetes care in the hospital: standards of care in diabetes-2026. Diabetes Care. 2026, 49:S339-55. 10.2337\/dc26-S016","journal-title":"Diabetes Care"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14192132","article-title":"The interlinking metabolic association between type 2 diabetes mellitus and cancer: molecular mechanisms and therapeutic insights","volume":"14","author":"Asiri A","year":"2024","unstructured":"Asiri A, Al Qarni A, Bakillah A. The interlinking metabolic association between type 2 diabetes mellitus and cancer: molecular mechanisms and therapeutic insights. Diagnostics (Basel). 2024, 14:2132. 10.3390\/diagnostics14192132","journal-title":"Diagnostics (Basel)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.70122","article-title":"Childhood acute leukemia and type 1 diabetes in children: a nationwide case-control study","volume":"158","author":"Ventel\u00e4 J","year":"2026","unstructured":"Ventel\u00e4 J, Pellikka I, Auvinen A, Lohi O, Nikkil\u00e4 A. Childhood acute leukemia and type 1 diabetes in children: a nationwide case-control study. Int J Cancer. 2026, 158:924-30. 10.1002\/ijc.70122","journal-title":"Int J Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-026-06077-w","article-title":"Co-occurrence of acute leukemia and type 1 diabetes among children: a caseseries","volume":"20","author":"Rosti H","year":"2026","unstructured":"Rosti H, Ventel\u00e4 J, Lohi O, Nikkil\u00e4 A. Co-occurrence of acute leukemia and type 1 diabetes among children: a caseseries. J Med Case Rep. 2026, 20:307. 10.1186\/s13256-026-06077-w","journal-title":"J Med Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s13410-021-01021-8","article-title":"Association between diabetes and acute lymphocytic leukemia, acute myeloid leukemia, non-Hodgkin lymphoma, and multiple myeloma","volume":"42","author":"Zhao JZ","year":"2022","unstructured":"Zhao JZ, Lu YC, Wang YM, et al.. Association between diabetes and acute lymphocytic leukemia, acute myeloid leukemia, non-Hodgkin lymphoma, and multiple myeloma. Int J Diabetes Dev Ctries. 2022, 42:694-702. 10.1007\/s13410-021-01021-8","journal-title":"Int J Diabetes Dev Ctries"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-024-08756-0","article-title":"Optimal hyperglycemia thresholds in patients undergoing chemotherapy: a cross sectional study of oncologists' practices","volume":"32","author":"Salgado TM","year":"2024","unstructured":"Salgado TM, Birari PB, Alshahawey M, et al.. Optimal hyperglycemia thresholds in patients undergoing chemotherapy: a cross sectional study of oncologists' practices. Support Care Cancer. 2024, 32:563. 10.1007\/s00520-024-08756-0","journal-title":"Support Care Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-025-02077-w","article-title":"Prevalence and risk factors of metabolic syndrome in survivors of childhood acute leukemia: a systematic review and meta-analysis","volume":"18","author":"Wei Z","year":"2026","unstructured":"Wei Z, Du Z, Liu H, Zheng J, Lu Q, Hu S. Prevalence and risk factors of metabolic syndrome in survivors of childhood acute leukemia: a systematic review and meta-analysis. Diabetol Metab Syndr. 2026, 18:47. 10.1186\/s13098-025-02077-w","journal-title":"Diabetol Metab Syndr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/508556-concomitant-diagnosis-of-acute-promyelocytic-leukemia-and-type-2-diabetes-mellitus-in-a-child-report-of-a-rare-case","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T09:49:57Z","timestamp":1782640197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/508556-concomitant-diagnosis-of-acute-promyelocytic-leukemia-and-type-2-diabetes-mellitus-in-a-child-report-of-a-rare-case"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,28]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.111647","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,28]]}}}